Browse studies

Find your next paid study

27,293 recruiting studies available now

Promoting Adolescent Health Behavior Change With Clinically Integrated Sample-Efficient Policy Gradient Methods

As most adolescents visit a healthcare provider once a year, health behavior change interventions linked to clinic-based health information technologies hold s…

Alcohol DrinkingSelf EfficacyAdolescent Behavior+2 more

Estimated

~$10 – $675

Actual pay is set by the research site.

University of California, San FranciscoNCT04110756

Phase 1

A Phase 1b, Open-label, Pilot Study of CLN-978 for the Treatment of Moderate to Severe Systemic Lupus Erythematosus (SLE)

Phase 1b, open-label study of CLN-978 administered subcutaneously in patients with Moderate to Severe Systemic Lupus Erythematosus (SLE).

SLESLE (Systemic Lupus)

Estimated

~$150 – $4,200

Actual pay is set by the research site.

Cullinan Therapeutics Inc.NCT06613360

Observational

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Mechanistic Effects of a Multi-Fiber Prebiotic Dietary Supplement (LOAM) on the Gut and Vaginal Microbiome, Gastrointestinal Well-Being, and Quality-of-Life Parameters in Women With Endometriosis and Co-Existing Gastrointestinal Symptoms

This study is a double-blind, randomized, placebo-controlled study that evaluates the safety and tolerability of a fiber-based dietary supplement and the mecha…

EndometriosisMicrobiome DysbiosisGastrointestinal Symptoms

Estimated

~$10 – $1,125

Actual pay is set by the research site.

LOAM ScienceNCT07875062

Phase 1

VALIENT: Phase 1 Clinical Trial of VorAsidenib in Combination With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations

This phase I study will evaluate the safety and tolerability of vorasidenib in combination with lomustine and determine the recommended combination dose (RCD) …

Recurrent GliomaIDH-mutant Gliomas

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Megan ManticaNCT07629089

Phase 2

Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity

The study will assign participants to take either the medication, empagliflozin or a placebo for 12 weeks. The goal of the study is to determine the effects of…

ObesityVascular Health

Estimated

~$75 – $1,800

Actual pay is set by the research site.

VA Office of Research and DevelopmentNCT06745063

Phase 2

Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Part 3 - Option II

The purpose of this study is to determine if experimental drug treatment improves recovery after TBI as compared to a control (placebo) group. Changes in recov…

Traumatic Brain Injury

Estimated

~$75 – $1,800

Actual pay is set by the research site.

University of California, San FranciscoNCT06790095

Phase 2

A Phase 2, Open-Label, Single-Arm Trial to Evaluate IV Rademikibart as an Add-on Treatment for Acute Exacerbation in Participants With Asthma and or COPD With Type 2 Inflammation

A Phase 2, open-label, single-arm trial to evaluate IV rademikibart as an add-on treatment for acute exacerbation in participants with asthma or COPD with type…

Asthma AcuteCOPD Exacerbation Acute

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Connect Biopharm LLCNCT07705737

Phase 3

Pragmatic Randomized Controlled Trial of Artificial Intelligence for Melanoma Diagnosis (PRACTA-MEL) (AI)

The purpose of this study is to learn whether a computer-based support tool called DEXI (Dermoscopy EXplainable Intelligence) can help dermatologists decide wh…

Malignant Melanoma of SkinOther and Unspecified Malignant Neoplasm of SkinMelanoma in Situ+13 more

Estimated

~$50 – $1,500

Actual pay is set by the research site.

Observational

Rural Community Peer Partnerships for Improving Methamphetamine-Associated Heart Failure Screening and Engagement

The goal of PEER-Heart is to implement and assess feasibility and preliminary effectiveness of a community peer-facilitated screening for methamphetamine-assoc…

Methamphetamine UseHeart Failure

Estimated

~$10 – $750

Actual pay is set by the research site.

Oregon Health and Science UniversityNCT06461962

Observational

Transitioning Recently Admitted Patients With Non-Insulin and Insulin-treated Type 2 Diabetes to Innovative Glucose Monitoring

The TRANSITION-CGM trial will evaluate whether starting continuous glucose monitoring (CGM) before hospital discharge improves blood glucose control in adults …

Type 2 Diabetes

Estimated

~$10 – $675

Actual pay is set by the research site.

University of CincinnatiNCT07890818

Phase 1

A Phase Ib/II, Multi-site, Open-label, Dose Finding Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of BNT326 in Combination With BNT327 in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)

This is a multi-site, open-label, dose-finding study, consisting of Parts 1, 2a, and 2b to investigate the combination of BNT326 with pumitamig (also known as …

Non-small Cell Lung Cancer

Estimated

~$150 – $4,500

Actual pay is set by the research site.

BioNTech SENCT07111520

Phase 2

A Phase 2, Open-Label, Randomized, Global Study of Three Telisotuzumab Vedotin Regimens in Subjects With Previously Treated c-Met Overexpressing, EGFR Wildtype, Locally Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor, a disease …

Non-Small Cell Lung Cancerc-MET

Estimated

~$75 – $3,000

Actual pay is set by the research site.

AbbVieNCT06568939